2. SinoFresh HealthCare Inc. is a publicly traded
marketer of innovative healthcare products
SinoFresh Homeopathic Nasal Spray relieves and
protects from airborne pathogens that cause
chronic sinusitis
SinoFresh Nasal Spray is patent protected
Re-launched in SE USA test market and through
e-commerce. Core distribution has been
reestablished
3. • Respiratory healthcare products innovator: SinoFresh
Homeopathic Nasal Spray targeted for 100 million
Americans with Sinusitis
• 3 additional products targeted for launch for the large,
growing respiratory market in next 9 months
• Strong patent portfolio
• Products are safe and easy to use with attractive margins
• Potential applications for treatment/prevention of MRSA,
N1H1 virus (Swine Flu)
4. Strong Int’l Patent Estate
FDA-approved manufacturer
E-commerce sales platform in place
Re-Launched SinoFresh Nasal Spray in West Coast of FL
test market
Throat Spray ready for launch in Q4’12 with strong new
product pipeline
EU registration process for Nasal Spray commenced
Significant core distribution network to build sales
5. •Sinusitis affects around 100m/yr in US
•Growing $5.8B annual US market
•Highly unsatisfied market
•67 approved products that only treat symptoms
•Sinusitis originates from numerous sources
•Potential to address range of health threats caused
by virulent, airborne pathogens, i.e., H1N1
(Swine Flu), Multi-resistant staph infection (MRSA)
6. •Antihistamines – Not indicated for sinusitis
•Topical Steroids – Reduce inflammation but long term
safety is an issue
•Oral Decongestants – Insomnia and cardiovascular issues
•Topical Decongestants – Rebound
•Environmental Controls – Difficult to maintain
•Antibiotics – Limited effectiveness and very expensive
7. • SinoFresh Homeopathic Nasal Spray is the only product
to directly target sinus and post nasal distress with
antiseptic cleansing of airborne pollutants, bacteria,
viruses, fungus, molds and pollens
• SinoFresh Homeopathic Nasal Spray attacks the cause of
sinusitis
• Topical, non-invasive, non-sedating and non-addictive
8. •Patented product
•Kills airborne human pathogens in the sinus and
nasal passages
•Attacks the cause of chronic sinusitis rather than
treat the symptoms
•Safely marketed for 9 years in the US
9. • Retail – Build on existing regional distribution in select
retail outlets: Publix, Wegmans, Independent Pharmacies,
McKesson, Cardinal Health, Miami-Luken, Drugstore.com,
and NationalAllergySupply.com
• E-commerce – Launched e-commerce retail on
www.sinofresh.com
• Retail Store Locator system will be added Q4 ‘12
10. •US alternate medicine market is $35B/p.a
•$22B in US sales for “self care” medicines
•Homeopathic self treatment sales have been growing
at a double digit rate due to low-cost vs high-cost of
some current OTC therapies
* Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative
medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007.
National health statistics reports; no 18. Hyattsville, MD: National Center for Health
Statistics. 2009.
11. •Institutional Healthcare Providers – Patients , staff
and facilities
•Government/Military
•Travel Industry and Travelers – Pathogen exposure
in closed environments, i.e., planes, cruise ships,
buses, trains, etc.
•International sales and distribution
•Pandemic Prevention – H1N1 (Swine Flu), MRSA
12. • Pilot in vivo study achieved a significant reduction in
MRSA levels
• Similar pilot animal testing for reduction of H1N1 (Swine
Flu) successfully completed with positive results
• Development of products for both prophylactic use and
treatment of both MRSA and H1N1 have enormous sales
potential
